Rationale to conduct trial of Tozorakimab is not adequate: CDSCO tells AstraZeneca Dr. Divya Colin11 Dec 2022 6:00 PM ISTNew Delhi: Citing that the rationale for conduct of the proposed trial of COPD (Chronic obstructive pulmonary disease) drug Tozorakimab is not...
Include more Govt sites: CDSCO panel to Zydus Healthcare on clinical trial of Pulmonary disease drug Susmita Roy10 Dec 2022 3:57 PM ISTNew Delhi: Citing that more Govt. sites should be included, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Folzest Vs Forzest: Delhi HC stays order involving Rs10 lakh penalty on Sun Pharma Tanya Bhutani9 Dec 2022 6:00 PM ISTDelhi: In a major relief to Sun Pharmaceuticals Ltd., the Delhi High Court has issued an order staying its earlier order in November that had imposed...
Zydus Gets CDSCO Panel Nod To Study Follitropin alfa Dr. Divya Colin8 Dec 2022 6:00 PM ISTNew Delhi: The drug major Zydus has got a green signal from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Cipla Gets CDSCO Panel Nod To Manufacture, Market FDC Tamsulosin plus Solifenacin Dr. Divya Colin7 Dec 2022 6:00 PM ISTNew Delhi: Pharmaceutical major, Cipla has got a go ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
HC upholds 30 percent cap on trade margin of 42 anti-cancer drugs Farhat Nasim6 Dec 2022 10:30 AM ISTNew Delhi: Observing that if policy to make cancer medicine affordable is not promulgated, majority of the country's population will be vulnerable to...
JB Pharma slashes price of critical Heart Failure medicine AZMARDA (Sacubitril-Valsartan) by nearly 50 percent Ruchika Sharma5 Dec 2022 2:37 PM IST"This move by JB will not only help reduce the cost of treatment but will also help enhance the productive years of patients and their quality of...
Sun Pharma gets CDSCO panel nod to manufacture, market Esomeprazole dual release gastroresistant tablets Susmita Roy4 Dec 2022 1:12 PM ISTNew Delhi: Pharmaceutical major Sun Pharma has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
AstraZeneca gets CDSCO Panel nod to market anticancer drug Acalabrutinib Susmita Roy3 Dec 2022 6:00 PM ISTNew Delhi: In a significant development, granting the proposal presented by drug major AstraZeneca Pharma India, the Subject Expert Committee (SEC)...
Furnish Price to Retailer and Moving Annual Turnover value in respect of 11 Formulations: NPPA Dr. Divya Colin2 Dec 2022 6:00 PM ISTNew Delhi: Taking an appropriate action for fixation of the ceiling prices pursuant to the issue of Revised Schedule-I of DPCO, 2013, the National...
NPPA fixes retail price of Sun pharma's Amoxycillin, Potassium Clavulanate Oral Suspension Susmita Roy1 Dec 2022 6:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
Drug Safety Alert: IPC Flags Adverse Reactions Linked To Norfloxacin Susmita Roy30 Nov 2022 6:00 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of November, has revealed that...
